...
首页> 外文期刊>Scientific reports. >Establishment of a Novel Primary Human Skeletal Myoblast Cellular Model for Chikungunya Virus Infection and Pathogenesis
【24h】

Establishment of a Novel Primary Human Skeletal Myoblast Cellular Model for Chikungunya Virus Infection and Pathogenesis

机译:基孔肯雅病毒感染和发病机理的新型原代人骨骼成肌细胞模型的建立。

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Chikungunya virus (CHIKV) is a re-emerging arbovirus known to cause chronic myalgia and arthralgia and is now considered endemic in countries across Asia and Africa. The tissue tropism of CHIKV infection in humans remains, however, ill-defined. Due to the fact that myositis is commonly observed in most patients infected with CHIKV, we sought to develop a clinically relevant cellular model to better understand the pathogenesis of CHIKV infection. In this study, primary human skeletal muscle myoblasts (HSMM) were established as a novel human primary cell line that is highly permissive to CHIKV infection, with maximal amounts of infectious virions observed at 16?hours post infection. Genome-wide microarray profiling analyses were subsequently performed to identify and map genes that are differentially expressed upon CHIKV infection. Infection of HSMM cells with CHIKV resulted in altered expressions of host genes involved in skeletal- and muscular-associated disorders, innate immune responses, cellular growth and death, host metabolism and virus replication. Together, this study has shown the establishment of a clinically relevant primary human cell model that paves the way for the further analysis of host factors and their involvement in the various stages of CHIKV replication cycle and viral pathogenesis.
机译:基孔肯雅病毒(CHIKV)是一种重新出现的虫媒病毒,已知会引起慢性肌痛和关节痛,现在在亚洲和非洲的国家被认为是地方性的。然而,人类CHIKV感染的组织趋向性仍然不确定。由于在大多数感染CHIKV的患者中普遍观察到肌炎这一事实,我们寻求建立临床相关的细胞模型以更好地了解CHIKV感染的发病机理。在这项研究中,原代人骨骼肌成肌细胞(HSMM)被确立为高度允许CHIKV感染的新型人类原代细胞系,在感染后16小时观察到最大数量的感染性病毒体。随后进行全基因组微阵列分析分析,以鉴定和定位在CHIKV感染后差异表达的基因。用CHIKV感染HSMM细胞导致与骨骼和肌肉相关疾病,先天免疫反应,细胞生长和死亡,宿主代谢和病毒复制有关的宿主基因表达发生改变。总之,这项研究表明建立了临床上相关的原代人类细胞模型,为进一步分析宿主因子及其在CHIKV复制周期和病毒发病机制各个阶段的参与铺平了道路。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号